Navigating GLP-1 providers can feel like a part-time job, and two names that consistently rise to the top are Ivim Health and Ro. Both offer access to semaglutide and tirzepatide, but they run on very different models — Ivim leans into lower-cost compounded options, while Ro is a brand-name-focused premium platform. This comparison breaks down scores, pricing, onboarding, medications, and support side by side. For the full breakdowns, see our Ivim Health review and Ro review, and compare both against the field in our provider directory.
| Feature | Ivim Health | Ro |
|---|---|---|
| GLP-1.Reviews Score | 4.9 / 5.0 | 4.5 / 5.0 |
| Starting Cost | $149 (compounded semaglutide) | $145/mo + medication |
| Medication Approach | Compounded options available | Brand-name only |
| Trustpilot | 4.9 | 3.7 |
| Best For | Self-pay value seekers | Brand-name seekers |
Criteria Ratings
Using the GLP-1.Reviews category framework, here’s how the two compare on our published scores:
| Category | Ivim Health | Ro |
|---|---|---|
| Clinical Quality | 5.0 | 5.0 |
| Support | 5.0 | 5.0 |
| Cost & Value | 4.8 | 4.6 |
| Trustpilot reputation | 4.9 | 3.7 |
The Onboarding Experience
The first hurdle in any GLP-1 journey is the medical consultation. Both use telehealth, but their approaches differ.
Ivim Health: Speed and Accessibility
Ivim is known for a streamlined, high-speed intake. Most users report a rapid turnaround between the initial questionnaire and a clinician’s authorization — a win for those who’ve done their research and are ready to start without delay.
Ro: Clinical Rigor
Ro positions itself as a premium platform. Onboarding is thorough, often requiring more detailed health history and, in some cases, lab work before a prescription is written. That can add a few days but provides a more traditional clinical feel.
Medication Types & Quality
Both focus on the heavy hitters of metabolic health: semaglutide (the active ingredient in Wegovy and Ozempic) and tirzepatide (in Zepbound and Mounjaro), drugs with strong trial evidence for weight loss (SURMOUNT-1, NEJM 2022).
- Ivim Health: offers compounded GLP-1 options, including compounded semaglutide starting at $149 — one of the more straightforward lower-cost entry points for self-pay users. Compounded drugs aren’t FDA-approved (FDA compounding guidance).
- Ro: focuses on brand-name GLP-1 access only, starting at $145/month plus the cost of medication — which can materially raise total monthly spend.
Not sure which route is right? Read our explainer on what GLP-1 medications are, including the difference between compounded and brand-name options.
Pricing: The Total-Monthly-Cost Breakdown
This is where the two diverge most. For a self-pay consumer, the difference between a “membership fee” and a “medication cost” is vital.
Ivim Health Pricing
Ivim’s compounded semaglutide starts at $149, with compounded access bundled through its telehealth program. That lower entry point is a big reason it scores well on Cost & Value (4.8).
Ro Pricing
Ro uses a membership-style structure ($145/month) for access to care, but it’s brand-name only — so the medication is an additional cost on top. For self-pay users without coverage, the total can climb quickly. For the full menu of consultation, lab, and shipping fees to watch for, see our guide to the real cost and hidden fees of GLP-1 programs.
Support and Long-Term Care
A major reason to choose a platform over a local clinic is 24/7 access to care. Ivim Health includes 1-on-1 health coaching in its membership — a big benefit for first-time users managing side effects like nausea — plus a private peer community. Ro offers similar clinical oversight with a more data-forward approach: top-tier app tracking and seamless care-team messaging that busy professionals tend to love.
Compounded vs. Brand-Name: What the Difference Means for You
The single biggest practical difference between these two providers is compounded versus brand-name medication — so it’s worth understanding what that means. Brand-name GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro) are FDA-approved, manufacturer-made, and quality-controlled to a national standard, but they carry high list prices and depend heavily on insurance. Compounded semaglutide and tirzepatide are mixed by compounding pharmacies to match the same active ingredient at a fraction of the cost, but they are not FDA-approved, so quality and consistency depend on the specific pharmacy a provider uses. Ro’s brand-name-only model gives you the regulatory assurance of the name-brand product; Ivim’s compounded options give you a far lower out-of-pocket price. Neither is universally “better” — it depends on whether your priority is FDA-approved sourcing or affordability, and whether your insurance will meaningfully offset a brand-name prescription.
Side Effects and Titration Support
Whichever you choose, the early months are where most people need help: nausea, constipation, and fatigue are common while the dose titrates up. Ivim’s included 1-on-1 coaching is geared toward exactly this — slowing the ramp, adjusting timing, and coaching the protein-and-hydration habits that reduce nausea. Ro leans on structured app-based tracking and care-team messaging, which suits users who prefer to self-manage with good data and quick clinician access. First-time users who want a human in their corner often favor Ivim’s coaching; experienced users who value a polished interface tend to prefer Ro.
Pros and Cons
Ivim Health
Pros: 4.9 overall score; 5.0 in Clinical Quality and Support; compounded semaglutide from $149; strong 4.9 Trustpilot reputation. Cons: compounded route won’t suit users who specifically want brand-name products; confirm access and trust details on the full review before enrolling.
Ro
Pros: 4.5 overall score; 5.0 in Clinical Quality and Support; ideal for a brand-name-only pathway; familiar platform with broader healthcare offerings. Cons: $145/month plus medication adds up fast for self-pay users; lower Cost & Value (4.6) and Trustpilot (3.7) than Ivim.
What Real Users Say
The gap in public reputation is one of the clearest signals here. Ivim Health carries a 4.9 Trustpilot rating, and the recurring themes in user feedback are fast onboarding, the genuinely helpful 1-on-1 coaching, and the predictability of the $149 compounded entry price. Ro sits notably lower at 3.7, and its reviews are more mixed: fans appreciate the brand-name access and the slick, data-rich app, but the common complaints center on total cost once medication is added and occasional friction getting timely support. That doesn’t make Ro a poor provider — it scores 4.5 overall and earns top marks for clinical quality — but for self-pay users specifically, the value and reputation edge clearly belongs to Ivim. As always, read the most recent reviews on each provider’s full page before enrolling, since promotions and pricing shift.
The Verdict: Which Is Right for You
- Choose Ivim Health if you want the higher overall score (4.9), stronger Cost & Value, compounded options, and a lower entry price with semaglutide at $149.
- Choose Ro if you specifically want a brand-name-only option and are comfortable with $145/month plus medication for access and care management.
Ivim stands out on value and public-review strength, while Ro remains a recognizable choice for brand-name prescribing. See how both rank against everyone else in our best overall GLP-1 providers guide, or read our related LifeMD vs. Mochi Health comparison.
Frequently Asked Questions
Is Ivim Health or Ro cheaper?
Ivim is generally cheaper for self-pay users: compounded semaglutide starts at $149 all-in, while Ro charges $145/month plus the cost of brand-name medication, which can push the total well above Ivim’s price.
Does Ro offer compounded semaglutide?
No. Ro focuses on brand-name GLP-1 access only (such as Wegovy and Zepbound). If you want lower-cost compounded semaglutide or tirzepatide, Ivim Health is the better fit.
Why does Ivim Health score higher than Ro?
Both earn top marks for clinical quality and support, but Ivim edges ahead on Cost & Value (4.8 vs. 4.6) and has a much stronger Trustpilot reputation (4.9 vs. 3.7), giving it a higher overall 4.9 vs. 4.5.
Which is better for a first-time GLP-1 user?
Ivim’s included 1-on-1 coaching and peer community make it especially friendly for first-timers managing early side effects, while Ro suits users who prefer a polished, data-driven app and specifically want brand-name medication.
Do Ivim Health and Ro accept insurance?
Ro can help pursue insurance for brand-name GLP-1s, since that’s its focus, though coverage for weight loss is never guaranteed. Ivim’s compounded options are self-pay and priced low enough ($149 to start) that many users skip insurance entirely. Confirm current terms with each provider before enrolling.
Can I get tirzepatide from Ivim Health or Ro?
Yes — both can provide tirzepatide (the active ingredient in Zepbound and Mounjaro). With Ivim it’s typically available as a lower-cost compounded option; with Ro it’s the brand-name product, billed on top of the monthly membership.
How fast can I get a prescription from Ivim or Ro?
Ivim is known for a fast, streamlined intake, with many users authorized shortly after completing the questionnaire. Ro’s onboarding is more thorough and sometimes requires lab work first, so it can take a few extra days — a trade-off of additional clinical rigor for a slightly slower start.
GLP-1.Reviews is an independent buyer’s guide and does not provide medical advice. Scores and pricing are 2026 estimates that can change. Consult a licensed healthcare professional before starting any medication.
Considering a compounded GLP-1 program? Read is TrimRx legit first.
For the complete cost and safety picture, check our Ivim Health cost.
Corrected 9 October 2026. We removed a generated image from this article. Generated images on this site no longer show certifications, organisations, products, prices or figures unless the specific claim has been checked.
Keep exploring our GLP-1 resources:
